Global Gabapentin Enacarbil Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gabapentin enacarbil is an anticonvulsant and analgesic drug of the gabapentinoid class, and a prodrug to gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be well tolerated and reasonably effective.
LPI (LP Information)' newest research report, the “Gabapentin Enacarbil Industry Forecast” looks at past sales and reviews total world Gabapentin Enacarbil sales in 2022, providing a comprehensive analysis by region and market sector of projected Gabapentin Enacarbil sales for 2023 through 2029. With Gabapentin Enacarbil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin Enacarbil industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin Enacarbil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin Enacarbil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gabapentin Enacarbil market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin Enacarbil and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin Enacarbil.
The global Gabapentin Enacarbil market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gabapentin Enacarbil is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gabapentin Enacarbil is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gabapentin Enacarbil is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gabapentin Enacarbil players cover Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, Pfizer, Depomed, Teva, Mylan and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Enacarbil market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Gabapentin Enacarbil market?
What factors are driving Gabapentin Enacarbil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin Enacarbil market opportunities vary by end market size?
How does Gabapentin Enacarbil break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Gabapentin enacarbil is an anticonvulsant and analgesic drug of the gabapentinoid class, and a prodrug to gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be well tolerated and reasonably effective.
LPI (LP Information)' newest research report, the “Gabapentin Enacarbil Industry Forecast” looks at past sales and reviews total world Gabapentin Enacarbil sales in 2022, providing a comprehensive analysis by region and market sector of projected Gabapentin Enacarbil sales for 2023 through 2029. With Gabapentin Enacarbil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin Enacarbil industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin Enacarbil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin Enacarbil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gabapentin Enacarbil market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin Enacarbil and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin Enacarbil.
The global Gabapentin Enacarbil market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gabapentin Enacarbil is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gabapentin Enacarbil is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gabapentin Enacarbil is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gabapentin Enacarbil players cover Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, Pfizer, Depomed, Teva, Mylan and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Enacarbil market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Capsule
- Tablet
- Post-Herpetic Neuralgia (PHN)
- Restless Legs Syndrome (RLS)
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Arbor Pharma
- Astellas
- GlaxoSmithKline
- Glenmark Pharma
- Pfizer
- Depomed
- Teva
- Mylan
- Novartis
- Apotex
- Sun Pharmaceutical
- Aurobindo Pharma
- Intas
- Amneal
- Marksans Pharma
- Alkem
- Jiangsu Enhua
- Jiangsu Hengrui
- Sailike Pharma
What is the 10-year outlook for the global Gabapentin Enacarbil market?
What factors are driving Gabapentin Enacarbil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin Enacarbil market opportunities vary by end market size?
How does Gabapentin Enacarbil break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin Enacarbil Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gabapentin Enacarbil by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gabapentin Enacarbil by Country/Region, 2018, 2022 & 2029
2.2 Gabapentin Enacarbil Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Enacarbil Sales by Type
2.3.1 Global Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
2.3.2 Global Gabapentin Enacarbil Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gabapentin Enacarbil Sale Price by Type (2018-2023)
2.4 Gabapentin Enacarbil Segment by Application
2.4.1 Post-Herpetic Neuralgia (PHN)
2.4.2 Restless Legs Syndrome (RLS)
2.4.3 Others
2.5 Gabapentin Enacarbil Sales by Application
2.5.1 Global Gabapentin Enacarbil Sale Market Share by Application (2018-2023)
2.5.2 Global Gabapentin Enacarbil Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gabapentin Enacarbil Sale Price by Application (2018-2023)
3 GLOBAL GABAPENTIN ENACARBIL BY COMPANY
3.1 Global Gabapentin Enacarbil Breakdown Data by Company
3.1.1 Global Gabapentin Enacarbil Annual Sales by Company (2018-2023)
3.1.2 Global Gabapentin Enacarbil Sales Market Share by Company (2018-2023)
3.2 Global Gabapentin Enacarbil Annual Revenue by Company (2018-2023)
3.2.1 Global Gabapentin Enacarbil Revenue by Company (2018-2023)
3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Company (2018-2023)
3.3 Global Gabapentin Enacarbil Sale Price by Company
3.4 Key Manufacturers Gabapentin Enacarbil Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin Enacarbil Product Location Distribution
3.4.2 Players Gabapentin Enacarbil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GABAPENTIN ENACARBIL BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin Enacarbil Market Size by Geographic Region (2018-2023)
4.1.1 Global Gabapentin Enacarbil Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gabapentin Enacarbil Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gabapentin Enacarbil Market Size by Country/Region (2018-2023)
4.2.1 Global Gabapentin Enacarbil Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gabapentin Enacarbil Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gabapentin Enacarbil Sales Growth
4.4 APAC Gabapentin Enacarbil Sales Growth
4.5 Europe Gabapentin Enacarbil Sales Growth
4.6 Middle East & Africa Gabapentin Enacarbil Sales Growth
5 AMERICAS
5.1 Americas Gabapentin Enacarbil Sales by Country
5.1.1 Americas Gabapentin Enacarbil Sales by Country (2018-2023)
5.1.2 Americas Gabapentin Enacarbil Revenue by Country (2018-2023)
5.2 Americas Gabapentin Enacarbil Sales by Type
5.3 Americas Gabapentin Enacarbil Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin Enacarbil Sales by Region
6.1.1 APAC Gabapentin Enacarbil Sales by Region (2018-2023)
6.1.2 APAC Gabapentin Enacarbil Revenue by Region (2018-2023)
6.2 APAC Gabapentin Enacarbil Sales by Type
6.3 APAC Gabapentin Enacarbil Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin Enacarbil by Country
7.1.1 Europe Gabapentin Enacarbil Sales by Country (2018-2023)
7.1.2 Europe Gabapentin Enacarbil Revenue by Country (2018-2023)
7.2 Europe Gabapentin Enacarbil Sales by Type
7.3 Europe Gabapentin Enacarbil Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin Enacarbil by Country
8.1.1 Middle East & Africa Gabapentin Enacarbil Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gabapentin Enacarbil Revenue by Country (2018-2023)
8.2 Middle East & Africa Gabapentin Enacarbil Sales by Type
8.3 Middle East & Africa Gabapentin Enacarbil Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin Enacarbil
10.3 Manufacturing Process Analysis of Gabapentin Enacarbil
10.4 Industry Chain Structure of Gabapentin Enacarbil
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin Enacarbil Distributors
11.3 Gabapentin Enacarbil Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN ENACARBIL BY GEOGRAPHIC REGION
12.1 Global Gabapentin Enacarbil Market Size Forecast by Region
12.1.1 Global Gabapentin Enacarbil Forecast by Region (2024-2029)
12.1.2 Global Gabapentin Enacarbil Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gabapentin Enacarbil Forecast by Type
12.7 Global Gabapentin Enacarbil Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Arbor Pharma
13.1.1 Arbor Pharma Company Information
13.1.2 Arbor Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Arbor Pharma Main Business Overview
13.1.5 Arbor Pharma Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Gabapentin Enacarbil Product Portfolios and Specifications
13.2.3 Astellas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Gabapentin Enacarbil Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Glenmark Pharma
13.4.1 Glenmark Pharma Company Information
13.4.2 Glenmark Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Glenmark Pharma Main Business Overview
13.4.5 Glenmark Pharma Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Gabapentin Enacarbil Product Portfolios and Specifications
13.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Depomed
13.6.1 Depomed Company Information
13.6.2 Depomed Gabapentin Enacarbil Product Portfolios and Specifications
13.6.3 Depomed Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Depomed Main Business Overview
13.6.5 Depomed Latest Developments
13.7 Teva
13.7.1 Teva Company Information
13.7.2 Teva Gabapentin Enacarbil Product Portfolios and Specifications
13.7.3 Teva Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Teva Main Business Overview
13.7.5 Teva Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Gabapentin Enacarbil Product Portfolios and Specifications
13.8.3 Mylan Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Gabapentin Enacarbil Product Portfolios and Specifications
13.9.3 Novartis Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Apotex
13.10.1 Apotex Company Information
13.10.2 Apotex Gabapentin Enacarbil Product Portfolios and Specifications
13.10.3 Apotex Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Apotex Main Business Overview
13.10.5 Apotex Latest Developments
13.11 Sun Pharmaceutical
13.11.1 Sun Pharmaceutical Company Information
13.11.2 Sun Pharmaceutical Gabapentin Enacarbil Product Portfolios and Specifications
13.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sun Pharmaceutical Main Business Overview
13.11.5 Sun Pharmaceutical Latest Developments
13.12 Aurobindo Pharma
13.12.1 Aurobindo Pharma Company Information
13.12.2 Aurobindo Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Aurobindo Pharma Main Business Overview
13.12.5 Aurobindo Pharma Latest Developments
13.13 Intas
13.13.1 Intas Company Information
13.13.2 Intas Gabapentin Enacarbil Product Portfolios and Specifications
13.13.3 Intas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Intas Main Business Overview
13.13.5 Intas Latest Developments
13.14 Amneal
13.14.1 Amneal Company Information
13.14.2 Amneal Gabapentin Enacarbil Product Portfolios and Specifications
13.14.3 Amneal Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Amneal Main Business Overview
13.14.5 Amneal Latest Developments
13.15 Marksans Pharma
13.15.1 Marksans Pharma Company Information
13.15.2 Marksans Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Marksans Pharma Main Business Overview
13.15.5 Marksans Pharma Latest Developments
13.16 Alkem
13.16.1 Alkem Company Information
13.16.2 Alkem Gabapentin Enacarbil Product Portfolios and Specifications
13.16.3 Alkem Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Alkem Main Business Overview
13.16.5 Alkem Latest Developments
13.17 Jiangsu Enhua
13.17.1 Jiangsu Enhua Company Information
13.17.2 Jiangsu Enhua Gabapentin Enacarbil Product Portfolios and Specifications
13.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Jiangsu Enhua Main Business Overview
13.17.5 Jiangsu Enhua Latest Developments
13.18 Jiangsu Hengrui
13.18.1 Jiangsu Hengrui Company Information
13.18.2 Jiangsu Hengrui Gabapentin Enacarbil Product Portfolios and Specifications
13.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Jiangsu Hengrui Main Business Overview
13.18.5 Jiangsu Hengrui Latest Developments
13.19 Sailike Pharma
13.19.1 Sailike Pharma Company Information
13.19.2 Sailike Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Sailike Pharma Main Business Overview
13.19.5 Sailike Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin Enacarbil Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gabapentin Enacarbil by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gabapentin Enacarbil by Country/Region, 2018, 2022 & 2029
2.2 Gabapentin Enacarbil Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Enacarbil Sales by Type
2.3.1 Global Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
2.3.2 Global Gabapentin Enacarbil Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gabapentin Enacarbil Sale Price by Type (2018-2023)
2.4 Gabapentin Enacarbil Segment by Application
2.4.1 Post-Herpetic Neuralgia (PHN)
2.4.2 Restless Legs Syndrome (RLS)
2.4.3 Others
2.5 Gabapentin Enacarbil Sales by Application
2.5.1 Global Gabapentin Enacarbil Sale Market Share by Application (2018-2023)
2.5.2 Global Gabapentin Enacarbil Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gabapentin Enacarbil Sale Price by Application (2018-2023)
3 GLOBAL GABAPENTIN ENACARBIL BY COMPANY
3.1 Global Gabapentin Enacarbil Breakdown Data by Company
3.1.1 Global Gabapentin Enacarbil Annual Sales by Company (2018-2023)
3.1.2 Global Gabapentin Enacarbil Sales Market Share by Company (2018-2023)
3.2 Global Gabapentin Enacarbil Annual Revenue by Company (2018-2023)
3.2.1 Global Gabapentin Enacarbil Revenue by Company (2018-2023)
3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Company (2018-2023)
3.3 Global Gabapentin Enacarbil Sale Price by Company
3.4 Key Manufacturers Gabapentin Enacarbil Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin Enacarbil Product Location Distribution
3.4.2 Players Gabapentin Enacarbil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GABAPENTIN ENACARBIL BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin Enacarbil Market Size by Geographic Region (2018-2023)
4.1.1 Global Gabapentin Enacarbil Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gabapentin Enacarbil Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gabapentin Enacarbil Market Size by Country/Region (2018-2023)
4.2.1 Global Gabapentin Enacarbil Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gabapentin Enacarbil Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gabapentin Enacarbil Sales Growth
4.4 APAC Gabapentin Enacarbil Sales Growth
4.5 Europe Gabapentin Enacarbil Sales Growth
4.6 Middle East & Africa Gabapentin Enacarbil Sales Growth
5 AMERICAS
5.1 Americas Gabapentin Enacarbil Sales by Country
5.1.1 Americas Gabapentin Enacarbil Sales by Country (2018-2023)
5.1.2 Americas Gabapentin Enacarbil Revenue by Country (2018-2023)
5.2 Americas Gabapentin Enacarbil Sales by Type
5.3 Americas Gabapentin Enacarbil Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin Enacarbil Sales by Region
6.1.1 APAC Gabapentin Enacarbil Sales by Region (2018-2023)
6.1.2 APAC Gabapentin Enacarbil Revenue by Region (2018-2023)
6.2 APAC Gabapentin Enacarbil Sales by Type
6.3 APAC Gabapentin Enacarbil Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin Enacarbil by Country
7.1.1 Europe Gabapentin Enacarbil Sales by Country (2018-2023)
7.1.2 Europe Gabapentin Enacarbil Revenue by Country (2018-2023)
7.2 Europe Gabapentin Enacarbil Sales by Type
7.3 Europe Gabapentin Enacarbil Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin Enacarbil by Country
8.1.1 Middle East & Africa Gabapentin Enacarbil Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gabapentin Enacarbil Revenue by Country (2018-2023)
8.2 Middle East & Africa Gabapentin Enacarbil Sales by Type
8.3 Middle East & Africa Gabapentin Enacarbil Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin Enacarbil
10.3 Manufacturing Process Analysis of Gabapentin Enacarbil
10.4 Industry Chain Structure of Gabapentin Enacarbil
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin Enacarbil Distributors
11.3 Gabapentin Enacarbil Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN ENACARBIL BY GEOGRAPHIC REGION
12.1 Global Gabapentin Enacarbil Market Size Forecast by Region
12.1.1 Global Gabapentin Enacarbil Forecast by Region (2024-2029)
12.1.2 Global Gabapentin Enacarbil Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gabapentin Enacarbil Forecast by Type
12.7 Global Gabapentin Enacarbil Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Arbor Pharma
13.1.1 Arbor Pharma Company Information
13.1.2 Arbor Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Arbor Pharma Main Business Overview
13.1.5 Arbor Pharma Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Gabapentin Enacarbil Product Portfolios and Specifications
13.2.3 Astellas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Gabapentin Enacarbil Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Glenmark Pharma
13.4.1 Glenmark Pharma Company Information
13.4.2 Glenmark Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Glenmark Pharma Main Business Overview
13.4.5 Glenmark Pharma Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Gabapentin Enacarbil Product Portfolios and Specifications
13.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Depomed
13.6.1 Depomed Company Information
13.6.2 Depomed Gabapentin Enacarbil Product Portfolios and Specifications
13.6.3 Depomed Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Depomed Main Business Overview
13.6.5 Depomed Latest Developments
13.7 Teva
13.7.1 Teva Company Information
13.7.2 Teva Gabapentin Enacarbil Product Portfolios and Specifications
13.7.3 Teva Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Teva Main Business Overview
13.7.5 Teva Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Gabapentin Enacarbil Product Portfolios and Specifications
13.8.3 Mylan Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Gabapentin Enacarbil Product Portfolios and Specifications
13.9.3 Novartis Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Apotex
13.10.1 Apotex Company Information
13.10.2 Apotex Gabapentin Enacarbil Product Portfolios and Specifications
13.10.3 Apotex Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Apotex Main Business Overview
13.10.5 Apotex Latest Developments
13.11 Sun Pharmaceutical
13.11.1 Sun Pharmaceutical Company Information
13.11.2 Sun Pharmaceutical Gabapentin Enacarbil Product Portfolios and Specifications
13.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sun Pharmaceutical Main Business Overview
13.11.5 Sun Pharmaceutical Latest Developments
13.12 Aurobindo Pharma
13.12.1 Aurobindo Pharma Company Information
13.12.2 Aurobindo Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Aurobindo Pharma Main Business Overview
13.12.5 Aurobindo Pharma Latest Developments
13.13 Intas
13.13.1 Intas Company Information
13.13.2 Intas Gabapentin Enacarbil Product Portfolios and Specifications
13.13.3 Intas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Intas Main Business Overview
13.13.5 Intas Latest Developments
13.14 Amneal
13.14.1 Amneal Company Information
13.14.2 Amneal Gabapentin Enacarbil Product Portfolios and Specifications
13.14.3 Amneal Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Amneal Main Business Overview
13.14.5 Amneal Latest Developments
13.15 Marksans Pharma
13.15.1 Marksans Pharma Company Information
13.15.2 Marksans Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Marksans Pharma Main Business Overview
13.15.5 Marksans Pharma Latest Developments
13.16 Alkem
13.16.1 Alkem Company Information
13.16.2 Alkem Gabapentin Enacarbil Product Portfolios and Specifications
13.16.3 Alkem Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Alkem Main Business Overview
13.16.5 Alkem Latest Developments
13.17 Jiangsu Enhua
13.17.1 Jiangsu Enhua Company Information
13.17.2 Jiangsu Enhua Gabapentin Enacarbil Product Portfolios and Specifications
13.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Jiangsu Enhua Main Business Overview
13.17.5 Jiangsu Enhua Latest Developments
13.18 Jiangsu Hengrui
13.18.1 Jiangsu Hengrui Company Information
13.18.2 Jiangsu Hengrui Gabapentin Enacarbil Product Portfolios and Specifications
13.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Jiangsu Hengrui Main Business Overview
13.18.5 Jiangsu Hengrui Latest Developments
13.19 Sailike Pharma
13.19.1 Sailike Pharma Company Information
13.19.2 Sailike Pharma Gabapentin Enacarbil Product Portfolios and Specifications
13.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Sailike Pharma Main Business Overview
13.19.5 Sailike Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gabapentin Enacarbil Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gabapentin Enacarbil Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Tablet
Table 5. Global Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 6. Global Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Table 7. Global Gabapentin Enacarbil Revenue by Type (2018-2023) & ($ million)
Table 8. Global Gabapentin Enacarbil Revenue Market Share by Type (2018-2023)
Table 9. Global Gabapentin Enacarbil Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 11. Global Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Table 12. Global Gabapentin Enacarbil Revenue by Application (2018-2023)
Table 13. Global Gabapentin Enacarbil Revenue Market Share by Application (2018-2023)
Table 14. Global Gabapentin Enacarbil Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Gabapentin Enacarbil Sales by Company (2018-2023) & (K Units)
Table 16. Global Gabapentin Enacarbil Sales Market Share by Company (2018-2023)
Table 17. Global Gabapentin Enacarbil Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Gabapentin Enacarbil Revenue Market Share by Company (2018-2023)
Table 19. Global Gabapentin Enacarbil Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Gabapentin Enacarbil Producing Area Distribution and Sales Area
Table 21. Players Gabapentin Enacarbil Products Offered
Table 22. Gabapentin Enacarbil Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gabapentin Enacarbil Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Gabapentin Enacarbil Sales Market Share Geographic Region (2018-2023)
Table 27. Global Gabapentin Enacarbil Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Gabapentin Enacarbil Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Gabapentin Enacarbil Sales Market Share by Country/Region (2018-2023)
Table 31. Global Gabapentin Enacarbil Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Gabapentin Enacarbil Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Gabapentin Enacarbil Sales by Country (2018-2023) & (K Units)
Table 34. Americas Gabapentin Enacarbil Sales Market Share by Country (2018-2023)
Table 35. Americas Gabapentin Enacarbil Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Gabapentin Enacarbil Revenue Market Share by Country (2018-2023)
Table 37. Americas Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 38. Americas Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 39. APAC Gabapentin Enacarbil Sales by Region (2018-2023) & (K Units)
Table 40. APAC Gabapentin Enacarbil Sales Market Share by Region (2018-2023)
Table 41. APAC Gabapentin Enacarbil Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Gabapentin Enacarbil Revenue Market Share by Region (2018-2023)
Table 43. APAC Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 44. APAC Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 45. Europe Gabapentin Enacarbil Sales by Country (2018-2023) & (K Units)
Table 46. Europe Gabapentin Enacarbil Sales Market Share by Country (2018-2023)
Table 47. Europe Gabapentin Enacarbil Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Gabapentin Enacarbil Revenue Market Share by Country (2018-2023)
Table 49. Europe Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 50. Europe Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Gabapentin Enacarbil Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Gabapentin Enacarbil Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Gabapentin Enacarbil
Table 58. Key Market Challenges & Risks of Gabapentin Enacarbil
Table 59. Key Industry Trends of Gabapentin Enacarbil
Table 60. Gabapentin Enacarbil Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Gabapentin Enacarbil Distributors List
Table 63. Gabapentin Enacarbil Customer List
Table 64. Global Gabapentin Enacarbil Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Gabapentin Enacarbil Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Gabapentin Enacarbil Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Gabapentin Enacarbil Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Gabapentin Enacarbil Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Gabapentin Enacarbil Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Gabapentin Enacarbil Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Gabapentin Enacarbil Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Gabapentin Enacarbil Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Gabapentin Enacarbil Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Gabapentin Enacarbil Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Gabapentin Enacarbil Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Gabapentin Enacarbil Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Gabapentin Enacarbil Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Arbor Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 79. Arbor Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 80. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Arbor Pharma Main Business
Table 82. Arbor Pharma Latest Developments
Table 83. Astellas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 84. Astellas Gabapentin Enacarbil Product Portfolios and Specifications
Table 85. Astellas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Astellas Main Business
Table 87. Astellas Latest Developments
Table 88. GlaxoSmithKline Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Gabapentin Enacarbil Product Portfolios and Specifications
Table 90. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Latest Developments
Table 93. Glenmark Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 94. Glenmark Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 95. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Glenmark Pharma Main Business
Table 97. Glenmark Pharma Latest Developments
Table 98. Pfizer Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Gabapentin Enacarbil Product Portfolios and Specifications
Table 100. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Depomed Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 104. Depomed Gabapentin Enacarbil Product Portfolios and Specifications
Table 105. Depomed Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Depomed Main Business
Table 107. Depomed Latest Developments
Table 108. Teva Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Gabapentin Enacarbil Product Portfolios and Specifications
Table 110. Teva Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Teva Main Business
Table 112. Teva Latest Developments
Table 113. Mylan Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan Gabapentin Enacarbil Product Portfolios and Specifications
Table 115. Mylan Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118. Novartis Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis Gabapentin Enacarbil Product Portfolios and Specifications
Table 120. Novartis Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Novartis Main Business
Table 122. Novartis Latest Developments
Table 123. Apotex Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 124. Apotex Gabapentin Enacarbil Product Portfolios and Specifications
Table 125. Apotex Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Apotex Main Business
Table 127. Apotex Latest Developments
Table 128. Sun Pharmaceutical Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 129. Sun Pharmaceutical Gabapentin Enacarbil Product Portfolios and Specifications
Table 130. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Sun Pharmaceutical Main Business
Table 132. Sun Pharmaceutical Latest Developments
Table 133. Aurobindo Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 134. Aurobindo Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 135. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Aurobindo Pharma Main Business
Table 137. Aurobindo Pharma Latest Developments
Table 138. Intas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 139. Intas Gabapentin Enacarbil Product Portfolios and Specifications
Table 140. Intas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Intas Main Business
Table 142. Intas Latest Developments
Table 143. Amneal Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 144. Amneal Gabapentin Enacarbil Product Portfolios and Specifications
Table 145. Amneal Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Amneal Main Business
Table 147. Amneal Latest Developments
Table 148. Marksans Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 149. Marksans Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 150. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Marksans Pharma Main Business
Table 152. Marksans Pharma Latest Developments
Table 153. Alkem Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 154. Alkem Gabapentin Enacarbil Product Portfolios and Specifications
Table 155. Alkem Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Alkem Main Business
Table 157. Alkem Latest Developments
Table 158. Jiangsu Enhua Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Enhua Gabapentin Enacarbil Product Portfolios and Specifications
Table 160. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Jiangsu Enhua Main Business
Table 162. Jiangsu Enhua Latest Developments
Table 163. Jiangsu Hengrui Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 164. Jiangsu Hengrui Gabapentin Enacarbil Product Portfolios and Specifications
Table 165. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Jiangsu Hengrui Main Business
Table 167. Jiangsu Hengrui Latest Developments
Table 168. Sailike Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 169. Sailike Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 170. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Sailike Pharma Main Business
Table 172. Sailike Pharma Latest Developments
Table 1. Gabapentin Enacarbil Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gabapentin Enacarbil Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Tablet
Table 5. Global Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 6. Global Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Table 7. Global Gabapentin Enacarbil Revenue by Type (2018-2023) & ($ million)
Table 8. Global Gabapentin Enacarbil Revenue Market Share by Type (2018-2023)
Table 9. Global Gabapentin Enacarbil Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 11. Global Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Table 12. Global Gabapentin Enacarbil Revenue by Application (2018-2023)
Table 13. Global Gabapentin Enacarbil Revenue Market Share by Application (2018-2023)
Table 14. Global Gabapentin Enacarbil Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Gabapentin Enacarbil Sales by Company (2018-2023) & (K Units)
Table 16. Global Gabapentin Enacarbil Sales Market Share by Company (2018-2023)
Table 17. Global Gabapentin Enacarbil Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Gabapentin Enacarbil Revenue Market Share by Company (2018-2023)
Table 19. Global Gabapentin Enacarbil Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Gabapentin Enacarbil Producing Area Distribution and Sales Area
Table 21. Players Gabapentin Enacarbil Products Offered
Table 22. Gabapentin Enacarbil Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gabapentin Enacarbil Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Gabapentin Enacarbil Sales Market Share Geographic Region (2018-2023)
Table 27. Global Gabapentin Enacarbil Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Gabapentin Enacarbil Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Gabapentin Enacarbil Sales Market Share by Country/Region (2018-2023)
Table 31. Global Gabapentin Enacarbil Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Gabapentin Enacarbil Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Gabapentin Enacarbil Sales by Country (2018-2023) & (K Units)
Table 34. Americas Gabapentin Enacarbil Sales Market Share by Country (2018-2023)
Table 35. Americas Gabapentin Enacarbil Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Gabapentin Enacarbil Revenue Market Share by Country (2018-2023)
Table 37. Americas Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 38. Americas Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 39. APAC Gabapentin Enacarbil Sales by Region (2018-2023) & (K Units)
Table 40. APAC Gabapentin Enacarbil Sales Market Share by Region (2018-2023)
Table 41. APAC Gabapentin Enacarbil Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Gabapentin Enacarbil Revenue Market Share by Region (2018-2023)
Table 43. APAC Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 44. APAC Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 45. Europe Gabapentin Enacarbil Sales by Country (2018-2023) & (K Units)
Table 46. Europe Gabapentin Enacarbil Sales Market Share by Country (2018-2023)
Table 47. Europe Gabapentin Enacarbil Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Gabapentin Enacarbil Revenue Market Share by Country (2018-2023)
Table 49. Europe Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 50. Europe Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Gabapentin Enacarbil Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Gabapentin Enacarbil Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Gabapentin Enacarbil Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Gabapentin Enacarbil Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Gabapentin Enacarbil
Table 58. Key Market Challenges & Risks of Gabapentin Enacarbil
Table 59. Key Industry Trends of Gabapentin Enacarbil
Table 60. Gabapentin Enacarbil Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Gabapentin Enacarbil Distributors List
Table 63. Gabapentin Enacarbil Customer List
Table 64. Global Gabapentin Enacarbil Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Gabapentin Enacarbil Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Gabapentin Enacarbil Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Gabapentin Enacarbil Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Gabapentin Enacarbil Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Gabapentin Enacarbil Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Gabapentin Enacarbil Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Gabapentin Enacarbil Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Gabapentin Enacarbil Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Gabapentin Enacarbil Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Gabapentin Enacarbil Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Gabapentin Enacarbil Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Gabapentin Enacarbil Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Gabapentin Enacarbil Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Arbor Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 79. Arbor Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 80. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Arbor Pharma Main Business
Table 82. Arbor Pharma Latest Developments
Table 83. Astellas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 84. Astellas Gabapentin Enacarbil Product Portfolios and Specifications
Table 85. Astellas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Astellas Main Business
Table 87. Astellas Latest Developments
Table 88. GlaxoSmithKline Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 89. GlaxoSmithKline Gabapentin Enacarbil Product Portfolios and Specifications
Table 90. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Latest Developments
Table 93. Glenmark Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 94. Glenmark Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 95. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Glenmark Pharma Main Business
Table 97. Glenmark Pharma Latest Developments
Table 98. Pfizer Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Gabapentin Enacarbil Product Portfolios and Specifications
Table 100. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Depomed Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 104. Depomed Gabapentin Enacarbil Product Portfolios and Specifications
Table 105. Depomed Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Depomed Main Business
Table 107. Depomed Latest Developments
Table 108. Teva Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Gabapentin Enacarbil Product Portfolios and Specifications
Table 110. Teva Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Teva Main Business
Table 112. Teva Latest Developments
Table 113. Mylan Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan Gabapentin Enacarbil Product Portfolios and Specifications
Table 115. Mylan Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118. Novartis Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis Gabapentin Enacarbil Product Portfolios and Specifications
Table 120. Novartis Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Novartis Main Business
Table 122. Novartis Latest Developments
Table 123. Apotex Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 124. Apotex Gabapentin Enacarbil Product Portfolios and Specifications
Table 125. Apotex Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Apotex Main Business
Table 127. Apotex Latest Developments
Table 128. Sun Pharmaceutical Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 129. Sun Pharmaceutical Gabapentin Enacarbil Product Portfolios and Specifications
Table 130. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Sun Pharmaceutical Main Business
Table 132. Sun Pharmaceutical Latest Developments
Table 133. Aurobindo Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 134. Aurobindo Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 135. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Aurobindo Pharma Main Business
Table 137. Aurobindo Pharma Latest Developments
Table 138. Intas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 139. Intas Gabapentin Enacarbil Product Portfolios and Specifications
Table 140. Intas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Intas Main Business
Table 142. Intas Latest Developments
Table 143. Amneal Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 144. Amneal Gabapentin Enacarbil Product Portfolios and Specifications
Table 145. Amneal Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Amneal Main Business
Table 147. Amneal Latest Developments
Table 148. Marksans Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 149. Marksans Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 150. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Marksans Pharma Main Business
Table 152. Marksans Pharma Latest Developments
Table 153. Alkem Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 154. Alkem Gabapentin Enacarbil Product Portfolios and Specifications
Table 155. Alkem Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Alkem Main Business
Table 157. Alkem Latest Developments
Table 158. Jiangsu Enhua Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Enhua Gabapentin Enacarbil Product Portfolios and Specifications
Table 160. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Jiangsu Enhua Main Business
Table 162. Jiangsu Enhua Latest Developments
Table 163. Jiangsu Hengrui Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 164. Jiangsu Hengrui Gabapentin Enacarbil Product Portfolios and Specifications
Table 165. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Jiangsu Hengrui Main Business
Table 167. Jiangsu Hengrui Latest Developments
Table 168. Sailike Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
Table 169. Sailike Pharma Gabapentin Enacarbil Product Portfolios and Specifications
Table 170. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Sailike Pharma Main Business
Table 172. Sailike Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gabapentin Enacarbil
Figure 2. Gabapentin Enacarbil Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin Enacarbil Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gabapentin Enacarbil Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gabapentin Enacarbil Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Tablet
Figure 11. Global Gabapentin Enacarbil Sales Market Share by Type in 2022
Figure 12. Global Gabapentin Enacarbil Revenue Market Share by Type (2018-2023)
Figure 13. Gabapentin Enacarbil Consumed in Post-Herpetic Neuralgia (PHN)
Figure 14. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2018-2023) & (K Units)
Figure 15. Gabapentin Enacarbil Consumed in Restless Legs Syndrome (RLS)
Figure 16. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2018-2023) & (K Units)
Figure 17. Gabapentin Enacarbil Consumed in Others
Figure 18. Global Gabapentin Enacarbil Market: Others (2018-2023) & (K Units)
Figure 19. Global Gabapentin Enacarbil Sales Market Share by Application (2022)
Figure 20. Global Gabapentin Enacarbil Revenue Market Share by Application in 2022
Figure 21. Gabapentin Enacarbil Sales Market by Company in 2022 (K Units)
Figure 22. Global Gabapentin Enacarbil Sales Market Share by Company in 2022
Figure 23. Gabapentin Enacarbil Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Gabapentin Enacarbil Revenue Market Share by Company in 2022
Figure 25. Global Gabapentin Enacarbil Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 28. Americas Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 29. APAC Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 30. APAC Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 31. Europe Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 32. Europe Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 35. Americas Gabapentin Enacarbil Sales Market Share by Country in 2022
Figure 36. Americas Gabapentin Enacarbil Revenue Market Share by Country in 2022
Figure 37. Americas Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 38. Americas Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 39. United States Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Gabapentin Enacarbil Sales Market Share by Region in 2022
Figure 44. APAC Gabapentin Enacarbil Revenue Market Share by Regions in 2022
Figure 45. APAC Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 46. APAC Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 47. China Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Gabapentin Enacarbil Sales Market Share by Country in 2022
Figure 55. Europe Gabapentin Enacarbil Revenue Market Share by Country in 2022
Figure 56. Europe Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 57. Europe Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 58. Germany Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 67. Egypt Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Gabapentin Enacarbil in 2022
Figure 73. Manufacturing Process Analysis of Gabapentin Enacarbil
Figure 74. Industry Chain Structure of Gabapentin Enacarbil
Figure 75. Channels of Distribution
Figure 76. Global Gabapentin Enacarbil Sales Market Forecast by Region (2024-2029)
Figure 77. Global Gabapentin Enacarbil Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Gabapentin Enacarbil Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Gabapentin Enacarbil Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Gabapentin Enacarbil Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Gabapentin Enacarbil Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Gabapentin Enacarbil
Figure 2. Gabapentin Enacarbil Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin Enacarbil Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gabapentin Enacarbil Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gabapentin Enacarbil Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Tablet
Figure 11. Global Gabapentin Enacarbil Sales Market Share by Type in 2022
Figure 12. Global Gabapentin Enacarbil Revenue Market Share by Type (2018-2023)
Figure 13. Gabapentin Enacarbil Consumed in Post-Herpetic Neuralgia (PHN)
Figure 14. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2018-2023) & (K Units)
Figure 15. Gabapentin Enacarbil Consumed in Restless Legs Syndrome (RLS)
Figure 16. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2018-2023) & (K Units)
Figure 17. Gabapentin Enacarbil Consumed in Others
Figure 18. Global Gabapentin Enacarbil Market: Others (2018-2023) & (K Units)
Figure 19. Global Gabapentin Enacarbil Sales Market Share by Application (2022)
Figure 20. Global Gabapentin Enacarbil Revenue Market Share by Application in 2022
Figure 21. Gabapentin Enacarbil Sales Market by Company in 2022 (K Units)
Figure 22. Global Gabapentin Enacarbil Sales Market Share by Company in 2022
Figure 23. Gabapentin Enacarbil Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Gabapentin Enacarbil Revenue Market Share by Company in 2022
Figure 25. Global Gabapentin Enacarbil Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 28. Americas Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 29. APAC Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 30. APAC Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 31. Europe Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 32. Europe Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Gabapentin Enacarbil Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Gabapentin Enacarbil Revenue 2018-2023 ($ Millions)
Figure 35. Americas Gabapentin Enacarbil Sales Market Share by Country in 2022
Figure 36. Americas Gabapentin Enacarbil Revenue Market Share by Country in 2022
Figure 37. Americas Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 38. Americas Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 39. United States Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Gabapentin Enacarbil Sales Market Share by Region in 2022
Figure 44. APAC Gabapentin Enacarbil Revenue Market Share by Regions in 2022
Figure 45. APAC Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 46. APAC Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 47. China Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Gabapentin Enacarbil Sales Market Share by Country in 2022
Figure 55. Europe Gabapentin Enacarbil Revenue Market Share by Country in 2022
Figure 56. Europe Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 57. Europe Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 58. Germany Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Application (2018-2023)
Figure 67. Egypt Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Gabapentin Enacarbil Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Gabapentin Enacarbil in 2022
Figure 73. Manufacturing Process Analysis of Gabapentin Enacarbil
Figure 74. Industry Chain Structure of Gabapentin Enacarbil
Figure 75. Channels of Distribution
Figure 76. Global Gabapentin Enacarbil Sales Market Forecast by Region (2024-2029)
Figure 77. Global Gabapentin Enacarbil Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Gabapentin Enacarbil Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Gabapentin Enacarbil Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Gabapentin Enacarbil Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Gabapentin Enacarbil Revenue Market Share Forecast by Application (2024-2029)
More Publications
Global Neurosurgery Consumables Market Growth 2023-2029
US$ 3,660.00
March 2023
92 pages
Global Cisplatin Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
134 pages
Global Artificial Vascular Grafts Market Growth 2024-2030
US$ 3,660.00
September 2024
111 pages
Global Medical Asparaginase Market Growth 2025-2031
US$ 3,660.00
March 2025
86 pages
Global Pulmonary Needles Market Growth 2023-2029
US$ 3,660.00
March 2023
97 pages
